MARIANI PETER J

Average Profitability
19.13%
Insider Buys Quantity
4
Insider Buys Sum
$97,263.84
Insider Sells Quantity
9
Insider Sells Sum
$2.32M

Insider Activity of MARIANI PETER J

According to the SEC Form 4 filings, MARIANI PETER J, being in a position of

  1. Chief Financial Officer at Cytosorbents Corporation,
    оver the last 12 months, has bought 51363 shares for $47,269, and sold 0 shares,
    over all time since 2024-12-11, has bought 51363 shares for $47,269, and sold 0 shares.

The largest purchase of all time was on 2016-10-07 and amounted to 6666 shares of AxoGen, Inc. for $49,995.

The largest sale of all time was on 2020-10-30 and amounted to 151366 shares of AxoGen, Inc. for $1.44M.

Biography of MARIANI PETER J

No biography is available at this moment.

2024-12-13PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
20,000
0.0335%
$0.96$19,294-13.46%
2024-12-12PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
20,000
0.0369%
$0.89$17,872+2.1%
2024-12-11PurchaseCytosorbents Corporation
CTSO
Chief Financial Officer
11,363
0.0201%
$0.89$10,103+2.23%
2023-12-11SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
12,500
0.0291%
$7.50$93,809+18.97%
2023-02-01SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,550
0.0348%
$9.36$136,188-11.25%
2023-01-31SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,320
0.0343%
$9.55$136,756-12.94%
2023-01-30SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
14,111
0.0334%
$9.69$136,736-15.26%
2023-01-27SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
20,940
0.0495%
$10.16$212,750-19.29%
2022-11-16SaleAxoGen, Inc.
AXGN
EVP & Chief Financial Officer
10,649
0.027%
$11.88$126,510-24.25%
2020-12-29SaleAxoGen, Inc.
AXGN
Chief Financial Officer
2,586
0.0033%
$8.90$23,028+8.43%
2020-12-21SaleAxoGen, Inc.
AXGN
Chief Financial Officer
962
0.0023%
$16.42$15,796+11.1%
2020-10-30SaleAxoGen, Inc.
AXGN
Chief Financial Officer
151,366
0.285%
$9.49$1.44M+50.52%
2016-10-07PurchaseAxoGen, Inc.
AXGN
Chief Financial Officer
6,666
0.0168%
$7.50$49,995+19.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.